Mediation between Bayer, plaintiffs seeks to clarify all justified claims: U.S. mediator


FILE PHOTO: The logo of Bayer AG is pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo

BERLIN (Reuters) – Mediation between Bayer and plaintiffs in the United States aims to clarify all justified claims related to Roundup herbicide both at the national and state level, mediator Ken Feinberg told a German magazine.

“The mediation is going slowly but steadily,” Wirtschaftswoche on Wednesday quoted Feinberg as saying.


Bayer is trying to reach a settlement after earlier court rulings against it. The German drugs and pesticides maker, which acquired Roundup and other glyphosate-based weed killers as part of its $63 billion takeover of Monsanto last year, faces potentially heavy litigation costs as plaintiffs claim Roundup causes cancer, something Bayer disputes.

Reporting by Riham Alkousaa; Editing by Michelle Martin


Articles You May Like

Singaporean cooks up Eid feast for migrant workers in lockdown
Philippines reports 11 coronavirus deaths, 163 more cases
Nearly half shuttered UK firms don’t know when they will reopen – ONS
80 million children at risk of measles, polio as vaccines disrupted: WHO, UNICEF
UK COVID-19 confirmed death toll rises 412 to 37,460

Leave a Reply

Your email address will not be published. Required fields are marked *